Louie S - Search Results

1

Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.

Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. Gill PS, et al. Among authors: louie s. J Natl Cancer Inst. 1997 Dec 3;89(23):1797-802. doi: 10.1093/jnci/89.23.1797. J Natl Cancer Inst. 1997. PMID: 9392621 Clinical Trial.

2

Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma.

Louie S, Cai J, Law R, Lin G, Lunardi-Iskandar Y, Jung B, Masood R, Gill P. Louie S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):455-60. doi: 10.1097/00042560-199504120-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7697441

3

The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.

Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC. Gill PS, et al. Among authors: louie s. N Engl J Med. 1996 Oct 24;335(17):1261-9. doi: 10.1056/NEJM199610243351702. N Engl J Med. 1996. PMID: 8857005 Free article. Clinical Trial.

4

Kaposi's sarcoma: advances in tumor biology and pharmacotherapy.

Sung JC, Louie SG, Park SY. Sung JC, et al. Among authors: louie sg. Pharmacotherapy. 1997 Jul-Aug;17(4):670-83. Pharmacotherapy. 1997. PMID: 9250545 Review.

5

Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.

Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. Gill PS, et al. Among authors: louie s. J Clin Oncol. 1999 Jun;17(6):1876-83. doi: 10.1200/JCO.1999.17.6.1876. J Clin Oncol. 1999. PMID: 10561228 Clinical Trial.

6

Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.

Garcia AA, Pujari M, Jeffers S, Iqbal S, Lenz HJ, Beringer P, Louie S. Garcia AA, et al. Among authors: louie s. Cancer Chemother Pharmacol. 2005 Jul;56(1):75-82. doi: 10.1007/s00280-004-0940-9. Epub 2005 Apr 5. Cancer Chemother Pharmacol. 2005. PMID: 15809878 Clinical Trial.

7

Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis.

Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti PS, Li Z, Lee AS, Gill PS. Liu R, et al. Among authors: louie s. Clin Cancer Res. 2013 Dec 15;19(24):6802-11. doi: 10.1158/1078-0432.CCR-13-1106. Epub 2013 Sep 18. Clin Cancer Res. 2013. PMID: 24048331 Free PMC article.

8

Clinical effects of biologic response modifiers.

Louie SG, Jung B. Louie SG, et al. Am J Hosp Pharm. 1993 Jul;50(7 Suppl 3):S10-8. Am J Hosp Pharm. 1993. PMID: 7689788 Review.

9

Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.

Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, Louie SG, Petasis NA, Schönthal AH. Kardosh A, et al. Cancer Res. 2008 Feb 1;68(3):843-51. doi: 10.1158/0008-5472.CAN-07-5555. Cancer Res. 2008. PMID: 18245486

10

The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.

LaBonte MJ, Manegold PC, Wilson PM, Fazzone W, Louie SG, Lenz HJ, Ladner RD. LaBonte MJ, et al. Int J Cancer. 2009 Dec 15;125(12):2957-69. doi: 10.1002/ijc.24658. Int J Cancer. 2009. PMID: 19536776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

687 results

Search Page

Filters